A multicenter open label Phase 2 study to evaluate the efficacy and saftey of Sutetnib maleate capsule in locally advanced or metastatic NSCLC
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Locally Advanced Or Metastatic Non-small Cell Lung Cancer.
-
Age: Between 18 Year(s) - 100 Year(s)
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Histopathological and/or cytopathological confirmation of locally advanced or metastatic NSCLC
- Confirmation that the tumor harbors an uncommon EGFR mutation
- A minimum life expectancy of over 3 months
You may not be eligible for this study if the following are true:
-
- have one of the EGFR mutation(s) required for this study
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.